Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Measure of Engagement of Epilepsy Patients in Messaging Groups

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03076645
Recruitment Status : Completed
First Posted : March 10, 2017
Last Update Posted : October 12, 2017
Sponsor:
Information provided by (Responsible Party):
Abbas Hasan, Royal Free Hospital NHS Foundation Trust

Brief Summary:
This study will measure the engagement of people with epilepsy in a mobile phone based messaging platform as well as understand if there is an impact on their self-management

Condition or disease Intervention/treatment Phase
Epilepsy Behavioral: Facilitator support and education Not Applicable

Detailed Description:

The primary purpose of this study is to assess a person with epilepsy's level of usage of a mobile messaging application for peer support. The secondary purpose is to understand what characteristics of their group drive different levels of usage and improvements in self-management.

Participants can participate as much or little as they want for a minimum of six weeks. Participants will complete an initial and a final questionnaire.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 202 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Measure of Engagement of Epilepsy Patients in Messaging Groups and Group Characteristics That Influence Engagement.
Actual Study Start Date : October 1, 2016
Actual Primary Completion Date : August 10, 2017
Actual Study Completion Date : August 10, 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Epilepsy

Arm Intervention/treatment
Experimental: Experimental
The Experimental Group will be placed in a group using the matching algorithm. Facilitator support and education intervention
Behavioral: Facilitator support and education
Group engaged with facilitator support and education




Primary Outcome Measures :
  1. Engagement [ Time Frame: 6 weeks ]
    Average participant number of posts over time frame assessed by tracking number of participant entries


Secondary Outcome Measures :
  1. Epilepsy self-management [ Time Frame: Change in Baseline to 6 weeks ]
    Patient activation measure based on self-reported questionnaire

  2. Epilepsy medication adherence [ Time Frame: Change in Baseline to 6 weeks ]
    Medication adherence based on self-reported questionnaire

  3. Epilepsy quality of life [ Time Frame: Change in Baseline to 6 weeks ]
    Quality of life in epilepsy metric based on self-reported questionnaire



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age, diagnosis of epilepsy, have access to a smartphone capable of running messaging application

Exclusion Criteria:

  • A diagnosis of learning disability/difficulty, significant mental health conditions; those in care, bereaved, or prisoners. Any other vulnerable individuals (individuals unable to protect themselves against significant harm or exploitation)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03076645


Locations
Layout table for location information
United Kingdom
Lewisham & Greenwich NHS Trust
Lewisham, United Kingdom, SE4 2LA
Barts and The London NHS Trust
London, United Kingdom, E1 1BB
Royal Free Hospital
London, United Kingdom, NW3 2QG
National Hospital for Neurology and Neurosurgery
London, United Kingdom, WC1N 3BG
Kent Community Health NHS Trust
Maidstone, United Kingdom, ME15 7AT
Sponsors and Collaborators
Royal Free Hospital NHS Foundation Trust
Investigators
Layout table for investigator information
Principal Investigator: Adina Nash Royal Free London NHS Foundation Trust

Layout table for additonal information
Responsible Party: Abbas Hasan, Honorary Researcher, Royal Free Hospital NHS Foundation Trust
ClinicalTrials.gov Identifier: NCT03076645     History of Changes
Other Study ID Numbers: 203594
First Posted: March 10, 2017    Key Record Dates
Last Update Posted: October 12, 2017
Last Verified: October 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: No current resource to share individual participant data. Data will be destroyed per protocol after due course and completion of study
Additional relevant MeSH terms:
Layout table for MeSH terms
Epilepsy
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases